Yearly Archives: 2010
PinPointe FootLaser Receives FDA Clearance
NuvoLase, Inc., a leader in podiatric light-based therapy, announced today the PinPointe™ FootLaser™ received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of nail fungus (onychomycosis). Continue reading
PinPointe FootLaser Receives TGA Approval
Released by PinPointe USA, Inc. on June 21, 2011
PinPointe FootLaser today announced it has received approval from the Therapeutic Goods Administration (TGA) for its new laser treatment for toenail fungus Onychomycosis), certifying it has met the TGA‘s consumer and health safety standards and can be offered… Continue reading
Australian to Offer PinPointe FootLaser
Released by PinPointe USA, Inc. on June 6, 2010
PinPointe USA, Inc., a privately held emerging medical device company developing advanced laser-based technology and products for the treatment of onychomycosis (toenail fungus) today announced that it has certified its first PinPointe FootLaser Provider… Continue reading
